Company news
OPKO Health, Inc. news in 2026
OPKO Health, Inc.'s news releases, calls and decks from 2026, newest first.
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
November 4, 2026
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
October 28, 2026
OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly
October 27, 2026
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
October 15, 2026
OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
September 8, 2026
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
August 13, 2026
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
July 27, 2026
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
July 23, 2026
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
June 15, 2026
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
May 12, 2026
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
April 30, 2026
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
April 30, 2026
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
April 28, 2026
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
April 22, 2026
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
April 21, 2026
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
April 7, 2026
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
February 26, 2026
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
February 26, 2026
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
February 12, 2026
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
February 3, 2026
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
Calls in 2026
Decks in 2026
- Q2 2026 Earnings Presentation
Earnings · 13 slides · Jul 27, 2026
- Q1 2026 Earnings Presentation
Earnings · 13 slides · Apr 28, 2026